---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-095024"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2025-09-30T23:59:59+00:00"
generated_at: "2026-05-17T05:18:10.030338+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zura Bio adopts Executive Severance Benefit Plan for CEO and named executives

## Summary
- CEO: 12 months base salary on regular termination; 18 months + 150% target bonus on change-in-control termination.
- Other named executives: 9 months base salary (regular) or 12 months + 100% target bonus (change-in-control).
- Plan effective September 24, 2025; requires signed release agreement for eligibility.
- Supersedes any prior severance agreements or arrangements for covered executives.

## SEC filing metadata
- accession: 0001104659-25-095024
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2025-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/0001104659-25-095024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/tm2527486d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-095024
- JSON: https://secwatch.observer/filing/0001104659-25-095024.json
- Plain text: https://secwatch.observer/filing/0001104659-25-095024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.